Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04333095 · ClinicalTrials.gov registry record · Phase 4
Sternal Block With Liposomal Bupivacaine vs. Saline Prior to Incision in Cardiac Surgery
A Phase 4 study, sponsored by Baylor Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT04333095 is a Phase 4 study that has completed, run by Baylor Research Institute. The registered enrollment target is 70 participants.
The verdict
NCT04333095, a Phase 4 study, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to find out what effects (good and bad) that the study medicine called "liposomal bupivacaine" has on subjects that are undergoing a sternotomy. Liposomal bupivacaine solution, is a drug that the doctor will inject before they make the cut through patient's breastbone (sternotomy). Normally pain medicine like this is given right before the surgeon closes up the patient's breastbone, at the end of the surgery. For this study, they want to see if giving the medicine before they make the cut into the patient's breastbone helps their pain. They also want to find out if patients feel less pain after surgery with the study drug than they do with saline and possibly decrease the need for pain medicine. Subjects will be in the study for about 72 hours or until they are discharged from the hospital.
Interventions
- DRUG Liposomal bupivacaine
- DRUG Normal Saline Flush, 0.9% Injectable Solution_#1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2020-02-06 |
| Est. Completion | 2021-06-26 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04333095
The ClinicalTrials.gov registry entry for NCT04333095 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Liposomal bupivacaine is the first listed.
NCT04333095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04333095 about?
NCT04333095 is a clinical study titled "Sternal Block With Liposomal Bupivacaine vs. Saline Prior to Incision in Cardiac Surgery". The purpose of this study is to find out what effects (good and bad) that the study medicine called "liposomal bupivacaine" has on subjects that are undergoing a sternotomy. Liposomal bupivacaine solution, is a drug that the doctor will inject before they make the cut through patient's breastbone (s...
What is the current status of trial NCT04333095?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2020-02-06. Estimated completion is 2021-06-26.
What interventions are being tested in trial NCT04333095?
The interventions under investigation include: Liposomal bupivacaine (DRUG), Normal Saline Flush, 0.9% Injectable Solution_#1 (DRUG).
Who is sponsoring clinical trial NCT04333095?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.